Point-Counter Point: Treating Corneal Haze with 0.8 mg/mL Topical Losartan

Innovative care often starts with a hypothesis and animal research. With that, there have been numerous basic science studies recently published demonstrating that topical losartan is able to reduce long-term corneal stromal haze. These studies have since paved the way for human trials.

Check out our Point-Counter Point article in Clinical Insights in Eyecare describing how to use topical losartan in clinical care.